Puma Biotechnology | PBYI - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Daiichi Sankyo JPY 500B 199.92B 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
Glaxosmithkline GBP 18.53B 1.29B 2026-03
Incyte USD 28.42M 994K 2026-06
MacroGenics USD 68.71M 1.29M 2026-03
Moderna USD 597M 6M 2026-06
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Takeda JPY 4.42T 50.32B 2026-06
TG Therapeutics USD 745.39M 247K 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12